Intrommune Therapeutics CEO, Michael Nelson, will discuss how the company’s technology can transform lives by allowing children and adults with food allergies to no longer live in fear simply by brushing their teeth.
Join this webinar to hear Pressure BioScience’s CEO, Richard Schumacher, talk about the unlimited potential of their expanded portfolio and their newest subsidiary, PBI Agrochem.
Join our webinar to hear from CAGE Bio CEO, Nitin Joshi as he discusses the opportunity this breakthrough technology presents.
For more than 30 years, Mary Tyler Moore led the JDRF and the fight against Type 1 Diabetes and its complications, including Diabetic Retinal Disease (DRD), the leading cause of blindness worldwide and a disease that affected her personally.
Please join our webinar to hear from AyuVis founder and CEO, Dr. Suchi Acharya, who will talk about the dire need for this treatment and the rapid progress that’s being made in saving the lives of these most vulnerable babies.
Cellular Preservation Technologies (CPT) has developed a patented medical device that increases the shelf life of platelets to 14 days working with the Vitalant, American Red Cross, Mayo Clinic, and others.
Unlocking a $13B marketing with topical biologics. CAGE Bio CEO, Nitin Joshi, discusses the opportunity this breakthrough technology presents.
Join Dr. Brian Levy, CEO of InflammX, and Andrew Gitkin, managing director and co-head of Health Care Investment Banking at Raymond James as they discuss the company and its new drug, Xiflam.
Hear the inventor of this technology, Dr. Reza Abdi and NanoTomer CEO, Jeff Bell present their pre-clinical data in preparation for an IND filing with the FDA.
Learn about the incredible progress that’s being made to achieve the Cancer Moonshot goals and what is still on the horizon.
1460 Broadway
New York, NY 10036
(917) 747-6198
© Copyright 2021 FORCE Family Office